申请人:LifeSci Pharmaceuticals, Inc.
公开号:US20190127366A1
公开(公告)日:2019-05-02
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds which are complement factor D inhibitors. Such compounds are useful for treating complement related disorders including, but are not limited to, autoimmune, inflammatory, and neurodegenerative diseases.